Skip to main content

Kimberlee (Kim) Drapkin

Equibles does not estimate personal net worth.

Get an email with a short summary when Climb Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get CLYM alerts

About Kimberlee (Kim) Drapkin

Kimberlee (Kim) Drapkin is recorded as Board Member at Climb Bio, Inc. (CLYM) since March 28, 2025. Climb Bio, Inc. reported in an 8-K filed April 1, 2025 that Kimberlee (Kim) Drapkin was appointed member of the Board, effective March 28, 2025. Climb Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Climb Bio, Inc. includes Aoife Brennan (CEO, CFO and Board Member), Aoife Brennan, M.B., Ch.B. (CEO and Board Member), Dr. Stephen Thomas (CEO) and 7 others.

“On March 28, 2025 (the "Effective Date"), the Board increased the size of the Board from seven to eight directors and, upon the recommendation of the nominating and corporate governance committee of the Board, elected each of Alexander (Bo) Cumbo and Kimberlee (Kim) Drapkin as members of the Board, effective immediately.”
Climb Bio, Inc. Form 8-K, filed April 1, 2025 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2025-03-28–present

Leadership on record at Climb Bio, Inc.

Recent activity